BerandaINO • NASDAQ
add
Inovio Pharmaceuticals Inc
Tutup sebelumnya
$1,76
Rentang hari
$1,73 - $1,86
Rentang tahun
$1,30 - $2,98
Kapitalisasi pasar
119,54Â jt USD
Volume Rata-Rata
1,55Â jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | — | — |
Biaya operasional | 7,88Â jt | -8,55% |
Penghasilan bersih | -45,50Â jt | -80,79% |
Margin laba bersih | — | — |
Penghasilan per saham | -0,87 | 2,25% |
EBITDA | -20,86Â jt | 22,53% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 50,80Â jt | -40,09% |
Total aset | 69,39Â jt | -35,19% |
Total liabilitas | 77,11Â jt | 130,03% |
Total ekuitas | -7,72 jt | — |
Saham yang beredar | 53,57 jt | — |
Harga terhadap nilai buku | -12,57 | — |
Tingkat pengembalian aset | -77,06% | — |
Tingkat pengembalian modal | -255,61% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -45,50Â jt | -80,79% |
Kas dari operasi | -21,57Â jt | 21,39% |
Kas dari investasi | 8,87Â jt | -37,01% |
Kas dari pembiayaan | 24,92Â jt | 3.672,40% |
Perubahan kas bersih | 12,22Â jt | 196,15% |
Arus kas bebas | 26,97Â jt | 254,39% |
Tentang
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
Didirikan
1999
Situs
Karyawan
134
